Home
Genpharmasec PE Ratio

Genpharmasec Ltd
NSE: GENPHARMASEC
PE
Key Highlights
- The P/E Ratio of Genpharmasec Ltd is 65.3 as of 10 May 9.00 AM .
- The P/E Ratio of Genpharmasec Ltd changed from 77.8 on March 2023 to 0 on March 2024 . This represents a CAGR of -100.00% over 2 years.
- The Latest Trading Price of Genpharmasec Ltd is ₹ 1.96 as of 09 May 15:30 .
- The PE Ratio of Trading Industry has changed from 28.3 to 68.2 in 5 years. This represents a CAGR of 19.23%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1. The PE Ratio of Trading industry is 68.2 in 2024.
Historical P/E Ratio of Genpharmasec Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Genpharmasec Ltd
Company Fundamentals for Genpharmasec Ltd

Genpharmasec Ltd
NSE: GENPHARMASEC
Share Price
Market Price of Genpharmasec Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
09 May 2025 | 1.96 |
08 May 2025 | 2.02 |
07 May 2025 | 2 |
06 May 2025 | 2.03 |
05 May 2025 | 2.06 |
02 May 2025 | 2.03 |
30 Apr 2025 | 2.03 |
29 Apr 2025 | 2.08 |
28 Apr 2025 | 2.07 |
25 Apr 2025 | 2.12 |
SWOT Analysis Of Genpharmasec Ltd
BlinkX Score for Genpharmasec Ltd
Asset Value vs Market Value of Genpharmasec Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Genpharmasec Ltd | 108.53 | 65.33 |
Adani Enterprises Ltd | 259893 | 60.7 |
Aegis Logistics Ltd | 27976 | 48.4 |
Redington Ltd | 20318 | 16.1 |
Cello World Ltd | 11825 | 34.8 |
Honasa Consumer Ltd | 7998 | 102.5 |
Company | |
---|---|
Genpharmasec Ltd | 108.53 |
Adani Enterprises Ltd | 259893 |
Aegis Logistics Ltd | 27976 |
Redington Ltd | 20318 |
Cello World Ltd | 11825 |
Honasa Consumer Ltd | 7998 |
PE Ratio of Genpharmasec Ltd Explained
₹108.53
Market cap
₹1
Earnings
65.3X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Trading Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Genpharmasec Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Genpharmasec Ltd
Historical Revenue, EBITDA and Net Profit of Genpharmasec Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Genpharmasec Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Genpharmasec Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Genpharmasec Ltd
About Genpharmasec Ltd
- Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as 'Adi Rasayan Limited'.
- The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992.
- Further, the name of Company was changed from 'Adi Rayasan Limited' to 'Genpharmasec Limited' on 27th November, 2018.
- Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited' to ' Genpharmasec Limited' on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai. The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat.
- Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market.
Genpharmasec Ltd News Hub
Genpharmasec standalone net profit rises 1866.67% in the June 2024 quarter
Net profit of Genpharmasec rose 1866.67% to Rs 0.59 crore in the quarter ended June 2024 as against
Read more
14 Aug 24
Genpharmasec to conduct board meeting
Genpharmasec will hold a meeting of the Board of Directors of the Company on 13 August 2024. Powered
Read more
08 Aug 24
Genpharmasec announces board meeting date
Genpharmasec will hold a meeting of the Board of Directors of the Company on 12 November 2024 Powere
Read more
07 Nov 24
Genpharmasec standalone net profit rises 9900.00% in the September 2024 quarter
Net profit of Genpharmasec rose 9900.00% to Rs 1.00 crore in the quarter ended September 2024 as aga
Read more
13 Nov 24